Cohen & Steers Inc (CNS) Stock Analysis

Verdict: AVOID

Premium P/E of 22x faces earnings misses and 6 analyst sell ratings, offset by a 4.0% dividend yield and robust 31% operating margins.

Investment score: 37/100

Analysis as of

Is Cohen & Steers Inc stock worth reviewing? The TradeMates thesis

The model recommends avoiding CNS stock due to a rich valuation (P/E 22.05x vs peer median 11.34x), three consecutive quarterly EPS misses, and persistent sell sentiment from institutional analysts.

7-factor investment score

Cohen & Steers Inc opportunities and risks

What speaks for CNS

What speaks against CNS

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
CNS22.0x6.2x16.5x76.6%28.1%3.3%
MAIN11.3x7.5x17.0x85.3%64.5%3.3%
HLNE13.6x5.8x9.3x69.9%32.1%7.9%
OTF8.2x3.6x17.9x77.5%27.2%-6.2%
FHI10.4x2.2x7.5x71.6%21.2%8.6%
AB10.5x9.6x9.6x100.0%91.0%9.5%
Peer median10.5x5.8x9.6x77.5%32.1%7.9%

Frequently asked questions about Cohen & Steers Inc (CNS)

Is CNS stock a good investment?

The TradeMates model rates Cohen & Steers Inc as AVOID with an investment score of 37/100. The model recommends avoiding CNS stock due to a rich valuation (P/E 22.05x vs peer median 11.34x), three consecutive quarterly EPS misses, and persistent sell sentiment from institutional analysts. This is algorithmic model output, not personal investment advice.

Is CNS stock a buy?

The TradeMates model verdict for CNS is AVOID with an investment score of 37/100. Treat this as a model signal to review, not a personal buy recommendation.